Kiniksa Pharmaceuticals International (KNSA) Operating Leases (2019 - 2026)
Kiniksa Pharmaceuticals International's (KNSA) quarterly Operating Leases came in at $4.9 million in Q2 2026, down 32.56% YoY from $7.2 million in Q2 2025, and down 16.57% on a QoQ basis from $5.9 million in Q1 2026.
Kiniksa Pharmaceuticals International (KNSA) Operating Leases (2019 - 2026) Analysis & Trends
Kiniksa Pharmaceuticals International (KNSA) has 8 years of Operating Leases data on file, last reported at $4.9 million in Q2 2026.
- Quarterly Operating Leases fell 32.56% year-over-year to $4.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $4.9 million (down 32.56% YoY) and the FY2025 annual result came in at $6.5 million, down 17.2% from the prior year.
- Operating Leases eased to $4.9 million in Q2 2026, from $5.9 million in the prior quarter.
- In the past five years, Operating Leases ranged from a high of $11.3 million in Q2 2023 to a low of $1.3 million in Q2 2022.
- A 5-year average of $6.6 million and a median of $7.1 million in 2025 frame the typical range for Operating Leases.
- Annual changes were most pronounced in 2022 — Operating Leases tumbled 63.49% — and 2023, when it soared 782.86%.
- Tracing KNSA's Operating Leases over 5 years: stood at $2.6 million in 2022, then jumped by 282.16% to $10.0 million in 2023, then fell by 21.42% to $7.9 million in 2024, then retreated by 17.2% to $6.5 million in 2025, then slipped by 24.96% to $4.9 million in 2026.
- The last three Operating Leases figures came in at $4.9 million (Q2 2026), $5.9 million (Q1 2026), and $6.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Kiniksa Pharmaceuticals International | 6.08 Bn | 5.56 Bn | 220.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.89 Mn |
| Mar 31, 2026 | 5.86 Mn |
| Dec 31, 2025 | 6.51 Mn |
| Sep 30, 2025 | 7.02 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 7.62 Mn |
| Dec 31, 2024 | 7.86 Mn |
| Sep 30, 2024 | 8.56 Mn |
| Jun 30, 2024 | 9.32 Mn |
| Mar 31, 2024 | 9.86 Mn |
| Dec 31, 2023 | 10.01 Mn |
| Sep 30, 2023 | 10.65 Mn |
| Jun 30, 2023 | 11.28 Mn |
| Mar 31, 2023 | 2.13 Mn |
| Dec 31, 2022 | 2.62 Mn |
| Sep 30, 2022 | 3.44 Mn |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 2.10 Mn |
| Dec 31, 2021 | 2.67 Mn |
| Sep 30, 2021 | 3.50 Mn |